11 Results for "

GLIS2

" in MedChemExpress (MCE) Product Catalog:
Products (11)

11 Results for "GLIS2" in MCE Product Catalog:

67
67 Cited Publications
Cat. No.: HY-13901
CAS No.: 500579-04-4
Purity:  99.66%
Synonyms: NSC 136476
Target:  

Gli Autophagy

Research Areas:  

Cancer

GANT 61 is an inhibitor of Gli1 and Gli2 targeting the Hedgehog/GLI pathway.
Cat. No.: HY-RS05481
Research Areas:  

Others

GLIS2 Human Pre-designed siRNA Set A contains three designed siRNAs for GLIS2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Cat. No.: HY-RS21582
Research Areas:  

Others

Glis2 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Glis2 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Cat. No.: HY-RS28100
Research Areas:  

Others

Glis2 Rat Pre-designed siRNA Set A contains three designed siRNAs for Glis2 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS05475
Research Areas:  

Others

GLI2 Human Pre-designed siRNA Set A contains three designed siRNAs for GLI2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Cat. No.: HY-RS27255
Research Areas:  

Others

Gli2 Rat Pre-designed siRNA Set A contains three designed siRNAs for Gli2 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

Cat. No.: HY-137567
CAS No.: 210976-81-1
Research Areas:  

Cancer

Prostaglandin E1 ethanolamide is an analog of prostaglandin E1 (PGE1) and may effectively inhibit GLI2-induced expression of target genes, including Gli1 and Ptch1, and tumor growth .
Cat. No.: HY-13901R
CAS No.: 500579-04-4
Synonyms: NSC 136476 (Standard)
Research Areas:  

Cancer

GANT 61 (Standard) is the analytical standard of GANT 61. This product is intended for research and analytical applications. GANT 61 is an inhibitor of Gli1 and Gli2 targeting the Hedgehog/GLI pathway.
Cat. No.: HY-12487
CAS No.: 1788896-33-2
Target:  

HDAC Hedgehog Gli

Research Areas:  

Cancer

NL-103 is an inhibitor of histone deacetylases (HDACs) and Hedgehog, with the IC50 values ​​of 21.3 nM, 57 nM, 74 nM, and 680 nM for HDAC1, HDAC2, HDAC3, and HDAC6, respectively. NL-103 can downregulate the expression of Gli2. NL-103 can be used in anti-cancer research .
Cat. No.: HY-RS20743
Research Areas:  

Others

Gli2 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Gli2 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Cat. No.: HY-183335
Research Areas:  

Cancer

Anticancer agent 321 is a Smoothened (SMO) inhibitor with a human IC50 of 0.12 μM, enhanced aqueous solubility, good plasma and metabolic stability, moderate therapeutic index, preliminary safety profile, and moderate oral bioavailability in rats.Anticancer agent 321 binds to SMO’s 7-transmembrane helical channel, forming hydrogen bonds with Asp384 and hydrophobic/π-π interactions with His470, Phe391, Tyr394, stabilizing SMO’s inactive conformation to inhibit Hedgehog/GLI signaling.Anticancer agent 321 inhibits proliferation, suppresses colony formation, induces apoptosis, and downregulates Hedgehog/GLI pathway target genes GLI1, GLI2, Ptch1, HHip in cancer cells.Anticancer agent 321 inhibits tumor growth, downregulates Ki67 and SOX2, and upregulates cleaved-caspase 3 in tumor tissues.Anticancer agent 321 can be used for the research of cutaneous squamous cell carcinoma .
  • 1